Mesenchymal stem cells in the management of therapy-resistant graft-versus-host disease:Turkish experience

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSezgin, G.
dc.contributor.authorPehlivan, M.
dc.contributor.authorSucak, G.
dc.contributor.authorKoc, Y.
dc.contributor.authorTopcuoglu, P.
dc.contributor.authorUnal, A.
dc.contributor.authorTanyeli, A.
dc.contributor.authorYilmaz, M.
dc.contributor.authorSonmez, M.
dc.contributor.authorOmay, S.
dc.contributor.authorUzay, A.
dc.contributor.authorHatip, S.
dc.contributor.authorOvali, E.
dc.date.accessioned2025-10-16T15:34:45Z
dc.date.issued2013
dc.description.abstract39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013
dc.identifier.otherWOS:000319025200189
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9398
dc.publisherNATURE PUBLISHING GROUP
dc.sourceBONE MARROW TRANSPLANTATION
dc.titleMesenchymal stem cells in the management of therapy-resistant graft-versus-host disease:Turkish experience
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS